GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Koninklijke Philips NV (BUE:PHG) » Definitions » ROE % Adjusted to Book Value

Koninklijke Philips NV (BUE:PHG) ROE % Adjusted to Book Value : 53.08% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Koninklijke Philips NV ROE % Adjusted to Book Value?

Koninklijke Philips NV's ROE % for the quarter that ended in Sep. 2024 was 6.37%. Koninklijke Philips NV's PB Ratio for the quarter that ended in Sep. 2024 was 0.12. Koninklijke Philips NV's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 53.08%.


Koninklijke Philips NV ROE % Adjusted to Book Value Historical Data

The historical data trend for Koninklijke Philips NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Koninklijke Philips NV ROE % Adjusted to Book Value Chart

Koninklijke Philips NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 572.00 1,168.00 2,683.00 -1,428.00 -

Koninklijke Philips NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 138.00 53.08

Competitive Comparison of Koninklijke Philips NV's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Koninklijke Philips NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Koninklijke Philips NV's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's ROE % Adjusted to Book Value falls into.



Koninklijke Philips NV ROE % Adjusted to Book Value Calculation

Koninklijke Philips NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-5.18% / N/A
=N/A

Koninklijke Philips NV's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.37% / 0.12
=53.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Koninklijke Philips NV ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Koninklijke Philips NV's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Koninklijke Philips NV Business Description

Address
Philips Center, Amstelplein 2, Amsterdam, NLD, 1096 BC
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.